Elevance Health (ELV) Scheduled to Post Quarterly Earnings on Thursday

Elevance Health (NYSE:ELV - Get Free Report) is set to post its quarterly earnings results before the market opens on Thursday, April 18th. Analysts expect Elevance Health to post earnings of $10.52 per share for the quarter. Individual interested in listening to the company's earnings conference call can do so using this link.

Elevance Health (NYSE:ELV - Get Free Report) last announced its earnings results on Wednesday, January 24th. The company reported $5.62 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $5.60 by $0.02. Elevance Health had a net margin of 3.49% and a return on equity of 20.47%. The business had revenue of $42.45 billion during the quarter, compared to analysts' expectations of $42.19 billion. During the same quarter last year, the company posted $5.23 EPS. The firm's revenue for the quarter was up 7.0% on a year-over-year basis. On average, analysts expect Elevance Health to post $37 EPS for the current fiscal year and $41 EPS for the next fiscal year.

Elevance Health Price Performance

NYSE:ELV traded down $5.78 during mid-day trading on Thursday, reaching $501.96. 849,052 shares of the company were exchanged, compared to its average volume of 1,023,862. Elevance Health has a 12 month low of $412.00 and a 12 month high of $521.18. The company has a fifty day moving average of $507.43 and a 200 day moving average of $480.44. The company has a quick ratio of 1.44, a current ratio of 1.44 and a debt-to-equity ratio of 0.59. The stock has a market cap of $116.81 billion, a PE ratio of 19.94, a PEG ratio of 1.12 and a beta of 0.78.

Elevance Health Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 22nd. Shareholders of record on Friday, March 8th were issued a dividend of $1.63 per share. The ex-dividend date was Thursday, March 7th. This represents a $6.52 dividend on an annualized basis and a yield of 1.30%. This is a positive change from Elevance Health's previous quarterly dividend of $1.48. Elevance Health's dividend payout ratio is currently 25.90%.

Analyst Ratings Changes

A number of equities research analysts have commented on ELV shares. Cantor Fitzgerald reissued an "overweight" rating and set a $580.00 price objective on shares of Elevance Health in a report on Wednesday. Wells Fargo & Company decreased their price objective on shares of Elevance Health from $561.00 to $557.00 and set an "overweight" rating on the stock in a report on Monday. StockNews.com lowered shares of Elevance Health from a "strong-buy" rating to a "buy" rating in a report on Thursday, January 25th. Barclays started coverage on shares of Elevance Health in a research note on Wednesday, March 6th. They issued an "overweight" rating and a $584.00 target price on the stock. Finally, Royal Bank of Canada raised their target price on shares of Elevance Health from $572.00 to $574.00 and gave the company an "outperform" rating in a research note on Thursday, January 25th. One research analyst has rated the stock with a hold rating and ten have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $569.00.

Insider Buying and Selling

In related news, Director Ramiro G. Peru sold 753 shares of Elevance Health stock in a transaction that occurred on Wednesday, February 7th. The shares were sold at an average price of $500.00, for a total transaction of $376,500.00. Following the transaction, the director now owns 9,109 shares of the company's stock, valued at approximately $4,554,500. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.29% of the stock is owned by insiders.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the company. Fortis Capital Advisors LLC bought a new position in Elevance Health during the 4th quarter worth approximately $29,000. Quarry LP bought a new position in Elevance Health during the 4th quarter worth approximately $30,000. TD Capital Management LLC acquired a new stake in Elevance Health during the 4th quarter worth approximately $30,000. O Dell Group LLC acquired a new stake in Elevance Health during the 4th quarter worth approximately $32,000. Finally, West Tower Group LLC acquired a new stake in Elevance Health during the 4th quarter worth approximately $35,000. Institutional investors own 89.24% of the company's stock.

Elevance Health Company Profile

Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.